Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wen‐Wen Sai"'
Autor:
Yu-lin Li, Jia-ying Xie, Bin Lu, Xiao-di Sun, Fang-fang Chen, Zhou-jie Tong, Wen-wen Sai, Wei Zhang, Zhi-hao Wang, Ming Zhong
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundCoronary heart disease (CHD) patients with standard low-density lipoprotein cholesterol (LDL-C) remain at risk of cardiovascular events, making it critical to explore new targets to reduce the residual risk. The relationship between β-shee
Externí odkaz:
https://doaj.org/article/460682a6c54a49b781a9d52ab0395567
Autor:
Guo‐Kai Shang, Lu Han, Zhi‐Hao Wang, Ya‐Peng Liu, Sen‐Bo Yan, Wen‐Wen Sai, Di Wang, Yi‐Hui Li, Wei Zhang, Ming Zhong
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1104-1120 (2020)
Abstract Background Sarcopenia causes several adverse events in elderly people. Muscle fibre atrophy and interstitial fibrosis are the main histopathological changes in sarcopenia and account for decreased muscle function. Tribbles homologue 3 (TRB3)
Externí odkaz:
https://doaj.org/article/08db9debcc474069a576334d59b5af8f
Autor:
Chun-yan Zheng, Xiao-ning Ni, Ke Zhang, Qi-yu Zhang, Sen-bo Yan, Wei Zhang, Wen-Wen Sai, Ming Zhong, Zhi-Hao Wang, Yun Ti
Publikováno v:
Molecular Immunology. 120:130-135
The complement system plays an important role in the development of acute coronary syndrome (ACS). Complement C1q is an important initial component of the classical complement pathway and closely related to many chronic inflammatory diseases, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e446680490496e45368c41a1a47ad5
https://doi.org/10.1016/j.molimm.2020.02.012
https://doi.org/10.1016/j.molimm.2020.02.012
Autor:
Lu Han, Wei Zhang, Yi-Hui Li, Ya-Peng Liu, Zhi-Hao Wang, Ming Zhong, Di Wang, Guo-Kai Shang, Sen-bo Yan, Wen-Wen Sai
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1104-1120 (2020)
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1104-1120 (2020)
Background Sarcopenia causes several adverse events in elderly people. Muscle fibre atrophy and interstitial fibrosis are the main histopathological changes in sarcopenia and account for decreased muscle function. Tribbles homologue 3 (TRB3) was prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ae7d9c8cbc9122812595e368c8cff23
http://europepmc.org/articles/PMC7432570
http://europepmc.org/articles/PMC7432570
PGF2α-FP Receptor Ameliorates Senescence of VSMCs in Vascular Remodeling by Src/PAI-1 Signal Pathway
Autor:
Bo-ang Hu, Wen-wen Sai, Jun Yuan, Hong-tao Lan, Jia Qi, Di Wang, Wei Zhang, Zhi-hao Wang, Ming Zhong, Yuan-yuan Shang
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2022 (2022)
Oxidative Medicine and Cellular Longevity, Vol 2022 (2022)
Senescence in vascular smooth muscle cells (VSMCs) is involved in vascular remodeling of aged mice. ProstaglandinF2α- (PGF2α-) FP receptor plays a critical role in cardiovascular diseases (CVDs), hypertension, and cardiac fibrosis. However, its rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cdd45b2831002a7a34550b24f495261
http://europepmc.org/articles/PMC8813271
http://europepmc.org/articles/PMC8813271
Autor:
Yan-Min Tan, Yulin Li, Jiaying Xie, Zhi-Hao Wang, Ming Zhong, Zhoujie Tong, Wen-Wen Sai, Hongtao Lan, Jie Peng, Wei Zhang
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-12 (2021)
Journal of Translational Medicine
Journal of Translational Medicine
Background The prevalence of metabolic syndrome (Mets) is closely related to an increased incidence of cardiovascular events. Angiopoietin-like protein 4 (ANGPTL4) is contributory to the regulation of lipid metabolism, herein, may provide a target fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::579ec16e3ff53348b37e811a8e1013f9
https://doi.org/10.1186/s12967-021-02739-z
https://doi.org/10.1186/s12967-021-02739-z
Autor:
Qi-ming Deng, Wei Zhang, Wen-Wen Sai, Xiao-Yan Wang, Zhi-Hao Wang, Sen-bo Yan, Ming Zhong, Jia-Wen Song, Ming Song, Guo-Kai Shang
Publikováno v:
American journal of cardiovascular drugs : drugs, devices, and other interventions. 20(2)
Levosimendan, a calcium sensitizer and potassium channel opener, has been demonstrated to improve myocardial function without increasing oxygen consumption and to show protective effects in other organs. Recently, a prospective, randomized controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672877c1c74c33f9b9ef51b667618fcb
https://pubmed.ncbi.nlm.nih.gov/31523760
https://pubmed.ncbi.nlm.nih.gov/31523760